HALO
HALOZYME THERAPEUTICS, INC.
Nasdaq: HALO · San Diego, CA · Healthcare
$81.93+1.09 (+1.35%)Closed
Market Cap$9.71B
Cash$309.7Mmost recent
Runwayprofitable
P/E (TTM)32.0EPS $2.56
52-Wk Range$57.73 – $81.93
Avg Volume2.0M3-month
Price & Trading Activity
Daily close with catalyst overlays and trading volume
$81.93+46.4%
Pipeline
Drug candidates sponsored by HALO · ClinicalTrials.gov
Couldn't load pipeline. ClinicalTrials.gov or the backend may be unavailable.
Valuation
Risk-adjusted NPV
Loading pipeline…
Peer comparison
Cohort check
No peer cohort defined for HALO. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.